These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 27366024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biologic drugs for inflammatory bowel disease.
    Yanai S, Matsumoto T.
    Nihon Rinsho; 2017 Mar; 75(3):403-407. PubMed ID: 30566782
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Next-Generation Therapeutics for IBD.
    Löwenberg M, D'Haens G.
    Curr Gastroenterol Rep; 2015 Jun; 17(6):21. PubMed ID: 26031830
    [Abstract] [Full Text] [Related]

  • 11. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
    Khan N, Asim H, Lichtenstein GR.
    Expert Opin Drug Saf; 2014 Dec 14; 13(12):1699-708. PubMed ID: 25406728
    [Abstract] [Full Text] [Related]

  • 18. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review.
    Byrne LW, McKay D.
    Surgeon; 2021 Oct 14; 19(5):e153-e167. PubMed ID: 34581275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First-Line Biologics or Small Molecules in Inflammatory Bowel Disease: a Practical Guide for the Clinician.
    Chang S, Hudesman D.
    Curr Gastroenterol Rep; 2020 Jan 30; 22(2):7. PubMed ID: 32002688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.